Proneurogenic Treatment for Amyloid or Tau-Based Neurodegeneration
针对淀粉样蛋白或 Tau 神经变性的促神经源性治疗
基本信息
- 批准号:9911993
- 负责人:
- 金额:--
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2017
- 资助国家:美国
- 起止时间:2017-01-01 至 2021-12-31
- 项目状态:已结题
- 来源:
- 关键词:AcuteAddressAlzheimer&aposs DiseaseAmyloidAmyloid beta-Protein PrecursorAnxietyBiological AssayBrain-Derived Neurotrophic FactorCellsCerebrumChronicCognitiveDementiaEngineeringEnsureEvaluationExerciseFrontotemporal DementiaHealthHippocampus (Brain)HumanImplantInjectionsInvestigationLoxP-flanked alleleMissionModelingMusNerve DegenerationNeurodegenerative DisordersNeurotrophic Tyrosine Kinase Receptor Type 2OralPharmaceutical PreparationsPharmacotherapyPhysical ExerciseProdrugsRoleSignal TransductionSmall Interfering RNATauopathiesTissuesVeteransabeta oligomerbasebehavior testcerebral amyloidosiscognitive performancecooperative studyeffective therapylearned behaviormetabotropic glutamate receptor 2mouse modelmutantneurogenesisnovel strategiesresponsestem cell therapytau Proteinstranscriptometranscriptome sequencing
项目摘要
Project Summary Abstract
Recent studies indicate that physical exercise exerts benefits on cognitive health, at least in
part, through effects on hippocampal neurogenesis. Other lines of investigation indicate that
physical exercise is essential for the optimum health, differentiation, and tissue integration of
therapeutic stem cell implants. The current proposal is focused on assessing the potential ability
of this compound, BCI-838, to mimic and/or potentiate the proneurogenic and procognitive
effects of physical exercise when studied in either the “Aβ oligomer only” model and a MAPT
P301L model of tauopathy. Developing effective treatments for both cerebral amyloidosis and
cerebral tauopathy is considered to be within the mission of the RRD section of VA ORD. In
order to assess the potential ability of a Group II mGluR antagonist (BCI-838) to mimic and/or
potentiate the proneurogenic and procognitive effects of physical exercise, Dutch mutant
APPE693Q “Aβ oligomer only” mice and MAPTP301L tauopathy mice will be undergo 3 mo
treatment with either (i) voluntary exercise only, (ii) proneurogenic drug treatment only (Group II
mGluR antagonist, BCI-838), or (iii) both. The treated mice will undergo behavioral tests to
assess their cognitive performance and anxiety levels. After finishing behavioral tests, their
hippocampi will be used for an assay of neurogenesis and RNAseq assay of transcriptome.
Because of the implication of BDNF in exercise-stimulated neurogenesis, we will also analyze
each type of mouse (wildtype, Aβ oligomer, tauopathy) for drug or exercise response after
crossing with either (i) a floxed/conditional Ntrk2(also known as trkB)-/- mouse or (iii) a
floxed/conditional Ntrk2F616A. The mouse is engineered such that all trkB signaling is acutely
abolished following oral treatment with the drug NMPP1. Together, the floxed trkB-/- and the
floxed Ntrk2F616A provide scenarios of chronic and acute deficiencies, respectively, of trkB
signaling. The floxed Ntrk2F616Awill also ensure that trkB signaling is abrogated in all relevant
cells. A third option for depleting the hippocampus of trkB is the injection of AAV-trkB siRNA.
The results of these studies could inform a novel approach to neurodegenerative diseases
aimed at stimulating hippocampal neurogenesis, through the use of physical exercise, mGluR
antagonists, trkB modulators, or some combination of two or more of these. Such an approach
could address a major unmet need among the over 500,000 Veterans now living with dementia.
This figure will only increase in the coming decades, and, if unchecked, threatens economies
worldwide.
项目摘要
最近的研究表明,体育锻炼对认知健康有益,至少在
部分是通过影响海马神经发生。其他调查线索表明,
体育锻炼对最佳健康、分化和组织整合至关重要。
治疗性干细胞移植目前的建议侧重于评估潜在的能力,
这种化合物BCI-838,以模拟和/或加强前神经和前认知
在“仅Aβ寡聚体”模型和MAPT中研究时,
tau蛋白病的P301 L模型。开发有效的治疗脑淀粉样变性和
脑tau蛋白病被认为在VA ORD的RRD部分的使命范围内。
为了评估第II组mGluR拮抗剂(BCI-838)模拟和/或
增强体育锻炼的前神经和前认知效应,荷兰突变体
APPE 693 Q“仅Aβ寡聚体”小鼠和MAPTP 301 L tau蛋白病小鼠将接受3个月的治疗。
用(i)仅自愿运动,(ii)仅前神经原性药物治疗(组II
mGluR拮抗剂,BCI-838),或(iii)两者。接受治疗的小鼠将接受行为测试,
评估他们的认知表现和焦虑水平。在完成行为测试后,
将使用Escampi进行神经发生测定和转录组的RNAseq测定。
由于BDNF在运动刺激的神经发生中的意义,我们还将分析
每种类型的小鼠(野生型、Aβ寡聚体、tau蛋白病)在给药后的药物或运动反应
与(i)floxed/条件性Ntrk 2(也称为trkB)-/-小鼠或(iii)
floxed/conditional Ntrk2F616A.小鼠被设计成使得所有trkB信号传导都被急性地
在用药物NMPP 1口服治疗后消除。同时,floxed trkB-/-和
floxed Ntrk 2F 616 A分别提供了trkB的慢性和急性缺乏的情况
发信号。floxed Ntrk 2F 616 A还将确保trkB信号在所有相关的
细胞耗尽海马体trkB的第三种选择是注射AAV-trkB siRNA。
这些研究的结果可以为神经退行性疾病提供新的方法
旨在刺激海马神经发生,通过使用体育锻炼,
拮抗剂、trkB调节剂或这些中的两种或更多种的某种组合。这种做法
可以解决目前患有痴呆症的50多万退伍军人中未满足的主要需求。
这一数字在未来几十年只会增加,如果不加以控制,将威胁到经济
国际吧
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
SAMUEL E. GANDY其他文献
SAMUEL E. GANDY的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('SAMUEL E. GANDY', 18)}}的其他基金
Proneurogenic Treatment for Amyloid or Tau-Based Neurodegeneration
针对淀粉样蛋白或 Tau 神经变性的促神经源性治疗
- 批准号:
10378457 - 财政年份:2017
- 资助金额:
-- - 项目类别:
Rehab Therapy Adjunct with a Neurogenic, Mnemoactive, A-Beta-Lowering Compound
含有神经源性、记忆活性、A-β 降低化合物的康复治疗辅助剂
- 批准号:
9220567 - 财政年份:2014
- 资助金额:
-- - 项目类别:
Rehab Therapy Adjunct with a Neurogenic, Mnemoactive, A-Beta-Lowering Compound
含有神经源性、记忆活性、A-β 降低化合物的康复治疗辅助剂
- 批准号:
8596270 - 财政年份:2014
- 资助金额:
-- - 项目类别:
Rehab Therapy Adjunct with a Neurogenic, Mnemoactive, A-Beta-Lowering Compound
含有神经源性、记忆活性、A-β 降低化合物的康复治疗辅助剂
- 批准号:
9026594 - 财政年份:2014
- 资助金额:
-- - 项目类别:
Rehab Therapy Adjunct with a Neurogenic, Mnemoactive, A-Beta-Lowering Compound
含有神经源性、记忆活性、A-β 降低化合物的康复治疗辅助剂
- 批准号:
8825927 - 财政年份:2014
- 资助金额:
-- - 项目类别:
Model for SorCS1-mediated Diabetes with Dementia
SorCS1 介导的糖尿病伴痴呆模型
- 批准号:
8599496 - 财政年份:2012
- 资助金额:
-- - 项目类别:
Generation and Characterization of Alzheimer Brain Cells
阿尔茨海默病脑细胞的生成和表征
- 批准号:
8370239 - 财政年份:2012
- 资助金额:
-- - 项目类别:
Model for SorCS1-mediated Diabetes with Dementia
SorCS1 介导的糖尿病伴痴呆模型
- 批准号:
8788636 - 财政年份:2012
- 资助金额:
-- - 项目类别:
Model for SorCS1-mediated Diabetes with Dementia
SorCS1 介导的糖尿病伴痴呆模型
- 批准号:
8411973 - 财政年份:2012
- 资助金额:
-- - 项目类别:
Model for SorCS1-mediated Diabetes with Dementia
SorCS1 介导的糖尿病伴痴呆模型
- 批准号:
8295466 - 财政年份:2012
- 资助金额:
-- - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
-- - 项目类别:
Fellowship
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
-- - 项目类别:
Continuing Grant
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
-- - 项目类别:
Research Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
-- - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
-- - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
-- - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
-- - 项目类别:
EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
-- - 项目类别:
Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
-- - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
-- - 项目类别:
Research Grant